Amir, el-A.D., Davis, K.L., Tadmor, M.D., Simonds, E.F., Levine, J.H., Bendall, S.C., Shenfeld, D.K., Krishnaswamy, S., Nolan, G.P., Pe'er, D. (2013). viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol, 31(6), 545-552. doi:10.1038/nbt.2594. PMID: 23685480, PMCID: PMC4076922

Bendall, S.C.*, Davis, K.L.*, Amir el, A.D.*, Tadmor, M. D., Simonds, E. F., Chen, T. J., Shenfield, D.K., Nolan, G.P., Pe'er, D. (2014). Single-cell trajectory detection uncovers progression and regulatory coordination in human B cell development. Cell, 157(3), 714-725. doi:10.1016/j.cell.2014.04.005. PMID: 24766814. PMCID: PMC4045247. *co-first author

Levine, J.H., Simonds, E.F., Bendall, S.C., Davis, K.L., Amir el, A.D., Tadmor, M.D., Litvin, O., Fienberg, H.G., Jager, A., Zunder, E.R., Finck, R., Gedman, A.L., Radtke, I., Downing, J.R., Pe’er, D., Nolan, G.P. (2015). Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis. Cell, 162(1), 184-197. doi:10.1016/j.cell.2015.05.047 PMID: 26095251. PMCID: PMC4508757.

Samusik, N., Good, Z., Spitzer, M.H., Davis, K.L., Nolan, G.P. (2016). Automated mapping of phenotype space with single-cell data. Nat Methods, 13(6), 493-496. doi:10.1038/nmeth.3863. PMID: 27183440. PMCID: PMC4896314.

Porpiglia, E., Samusik, N., Van Ho, A.T., Cosgrove, B.D., Davis, K.L., Jager, A., Nolan, G.P., Bendall, S.C., Fantl, W.J., Blau, H.M. (2017). High-resolution myogenic lineage mapping by single-cell mass cytometry. Nat Cell Biol, 19(5), 558-567. doi:10.1038/ncb3507. PMID: 28414312. PMCID: PMC5728993.

Savino, A.M., Sarno, J., Trentin, L., Vieri, M., Fazio, G., Bardini, M., Bugarin, C., Fossati, G., Davis, K.L., Gaipa, G., Izraeli, S., Meyer, S., Nolan, G.P., Biondi, A., Te Kronnie, G., Palmi, C.,  Cazzaniga, G. (2017). The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL. Leukemia, 31(11), 2365-2375. doi:10.1038/leu.2017.93. PMID: 28331226.

Davis, K.L., Agarwal, A., Verna, A. Checkpoint inhibition in pediatric hematologic malignancies. Pediatr Hematol Oncol. 2017 Nov 30:1-16. doi: 10.1080/08880018.2017.1383542. PMID: 29190182.

Schultz, L. M., Majzner, R., Davis, K. L., & Mackall, C. (2017). New developments in immunotherapy for pediatric solid tumors. Curr Opin Pediatr. doi:10.1097/mop.0000000000000564. PMID: 29189429.

Kunicki, M.A., Amaya Hernandez, L.C., Davis, K.L., Bacchetta, R., and Roncarolo, M.G. (2017). Identity and Diversity of Human Peripheral Th and T Regulatory Cells Defined by Single-Cell Mass Cytometry. J Immunol. doi:10.4049/jimmunol.1701025. PMID: 29180490.

Maude S.L., Laetsch T.W., Buechner J., Rives S., Boyer M., Bittencourt H., Bader P., Verneris M.R., Stefanski H.E., Myers G.D., Qayed M., De Moerloose B., Hiramatsu H., Schlis K., Davis K.L., Martin P.L., Nemecek E.R., Yanik G., Peters C., Baruchel A., Boissel N., Mechinaud F., Balduzzi A., Krueger J., June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT, Zhang Y, Sen K, Lebwohl D, Pulsipher MA, Grupp SA. Tisagenlecleucel in Children and Young Adults with B Lymphoblastic Leukemia. N Engl J Med, 2018 Feb 1;378(5):439-488. PMID: 29385370. PMCID: PMC5996391. *Contributed equally to this work.

Good, Z., Sarno, J., Jager, A., Samusik, N., Agaheepoor, N., Simonds, E.F., White, L., Lacayo, N.J., Fantl, W.J., Tibshirani, R., Gaipa, G., Biondi, A., Bendall, S.C., Nolan, §G.P., Davis, §K.L. Single-cell developmental classification of B-cell precursor acute lymphoblastic leukemia at diagnosis reveals developmentally dependent predictors of relapse. Nat Med, 2018 May. [Epub ahead of print] 2018 Mar 5. doi: doi: 10.1038/nm.4505. §Co-senior author. PMID: 29505032

Anchang, B., Davis, K., Fienberg, H., Karacosta, L., Bendall, S.C., Tibshirani, R., Nolan, G., and Plevritis, S.K. DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity. Proc Natl Acad Sci U S A, 2018 May 1;115(18). PMID: 29654148. PMCID: PMC5939057.

Sarno, J., Savino, A.M., Buracchi, C., Palmi, C., Pinto, S., Bugarin, C., Jager, A., Bresolin, S., Barber, R.C., Silvestri, D., Israeli, S., Dyer, M.J.S., Cazzaniga, G., Nolan, G.P., Biondi, A., Davis, K.L.* and Gaipa, G.* SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell Acute Lymphoblastic Leukemia. Oncotarget, 2018 May. PMID: 29796158. PMCID: PMC5955419. *These authors have contributed equally to this work

Laetsch TW, Maude SL, Milone MC, Davis KL, Krueger J, Cardenas AM, Eldjerou LK, Keir CH, Wood PA, and Grupp SA. False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapy. Blood, 2018 June 7:131(23):2596-2598. doi: 10.1182/blood-2017-12-822940. PMID: 29669777.

Lin JK, Lerman BJ, Barnes JI, Boursiquot BC, Tan YJ, Robinson AQL, Davis KL, Owens DK, Goldhaber-Fiebert JD. Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia. J Clin Oncol, 2018 Sep 13. PMID: 30212291.

Diaz-Flores E, Comeaux EQ, Kim KL, Melnik EM, Beckman K, Davis KL, Wu K, Akutagawa J, Bridges O, Marino R, Wohlfeil M, Braun BA, Mullighan CG, Loh ML. BCL-2 is a Therapeutic Target For Hypodiploid B-Lineage Acute Lymphoblastic Leukemia. Cancer Res, 2019 Mar 12. PMID: 30862722